|4Nov 25, 4:33 PM ET

Johnson Craig A 4

4 · Aurinia Pharmaceuticals Inc. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-21
Transactions
  • Award

    Director Stock Option (right to buy)

    2024-11-21+31,68831,688 total
    Exercise: $8.24Exp: 2034-11-21Common Shares (31,688 underlying)
  • Award

    Common Shares

    2024-11-21+20,63120,631 total
Footnotes (2)
  • [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
  • [F2]The options shall vest one year from date of grant.

Documents

1 file
  • 4
    wk-form4_1732570412.xmlPrimary

    FORM 4